BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23258240)

  • 21. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease.
    Eraslan S; Kizilgul M; Uzunlulu M; Colak Y; Ozturk O; Tuncer I
    Minerva Med; 2013 Aug; 104(4):447-53. PubMed ID: 24008607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease].
    Topil'skaia NV; Morozov SV; Isakov VA; Trufanova IuM; Kaganov BS
    Eksp Klin Gastroenterol; 2011; (6):26-31. PubMed ID: 22168074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.
    de Abreu VG; Martins CJM; de Oliveira PAC; Francischetti EA
    PLoS One; 2017; 12(7):e0180947. PubMed ID: 28746378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.
    Gentili A; Daviddi G; De Vuono S; Ricci MA; Di Filippo F; Alaeddin A; Mannarino MR; Boni M; Vaudo G; Lupattelli G
    Dig Liver Dis; 2016 Aug; 48(8):904-8. PubMed ID: 27160697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA; Dudanova OP; Kurbatova IV
    Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.
    Andrade GC; Fujise LH; Santana JE; Oliveira F; Silva Rde C
    Rev Assoc Med Bras (1992); 2016; 62(3):218-26. PubMed ID: 27310544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.
    Ozcelik F; Yuksel C; Arslan E; Genc S; Omer B; Serdar MA
    Arch Med Res; 2013 May; 44(4):273-80. PubMed ID: 23602473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
    Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
    J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.
    Tasliyurt T; Gokce E; Sahin S; Aslan AB; Demir AK; Uzun S; Kutluturk F
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):952-958. PubMed ID: 32077835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
    Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
    J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.